Stock listing

NASDAQ:AKRO Akero Therapeutics Inc Stock

Follow Akero Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:AKRO

$54.65 USD

Close on Dec 9, 2025 · No longer trades

Jun 20, 2019 to last close +198.3% · weekly closes, Jun 20, 2019 – Dec 9, 2025
Lowest – highest close
$8.00 – $57.56 USDSince Jun 20, 2019 · lowest Jun 1, 2022 · highest Feb 5, 2025

Delisted NASDAQ:AKRO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AKRO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Akero Therapeutics Inc on 6ix

Decks
16 decks · latest Jan 27, 2025

Decks

DeckKindSlidesDate
Investor Presentation (January 2025)Investor deck71 slidesJan 27, 2025
Technical Presentation (January 2025)Technical22 slidesJan 27, 2025
Technical Presentation (March 2024)Technical23 slidesMar 4, 2024
Technical Presentation (October 2023)Technical25 slidesOct 10, 2023
Investor Presentation (June 2023)Investor deck64 slidesJun 5, 2023
Technical Presentation (September 2022)Technical21 slidesSep 13, 2022
Investor Presentation (June 2022)Investor deck45 slidesJun 8, 2022
Investor Presentation (September 2021)Investor deck40 slidesSep 9, 2021
Investor Presentation (May 2021)Investor deck46 slidesMay 13, 2021
Investor Presentation (April 2021)Investor deck46 slidesApr 13, 2021
All 16 decks
DeckKindSlidesDate
JP Morgan Healthcare Conference 2021Conference33 slidesJan 11, 2021
Investor Presentation (November 2020)Investor deck32 slidesNov 16, 2020
Technical Presentation (June 2020)Technical21 slidesJun 30, 2020
Corporate Update (March 2020)Corporate update10 slidesMar 31, 2020
Investor Presentation (January 2020)Investor deck19 slidesJan 13, 2020
Investor Presentation (September 2019)Investor deck19 slidesSep 6, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jane Pritchett Henderson
Other companies: CARGO Therapeutics, Inc. (Director · Since at least Jun 3, 2024); Apogee Therapeutics, Inc. (Chief Financial Officer · Since at least Jul 13, 2023); Invivyd, Inc. (Chief Financial Officer · Aug 5, 2021 – Jan 30, 2022 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – May 3, 2021 · Past); IVERIC bio Inc (Director · Jan 13, 2018 – Jul 11, 2023 · Past); Voyager Therapeutics, Inc. (Sr. V.P. & CFO, Corp. Dev. · Jan 1, 2017 – Mar 22, 2018 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past)
Director · Since at least Jun 19, 2019
Mark Iwicki
Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past); Aimmune Therapeutics Inc (Director · May 25, 2016 – Oct 10, 2020 · Past)
Director · Since at least Jun 19, 2019
Tomas J. Heyman
Other companies: Legend Biotech Corp. (Director · Since at least Mar 18, 2026); Exelixis, Inc. (Director · Since at least May 31, 2023); Xilio Therapeutics, Inc. (Director · Sep 15, 2022 – Jun 12, 2023 · Past); Invivyd, Inc. (Director · Aug 5, 2021 – May 23, 2023 · Past); OptiNose (Director · Dec 1, 2020 – May 21, 2025 · Past)
Director · Since at least Jun 9, 2020
Aaron E. Royston
Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); Achieve Life Sciences, Inc. (Director · Since at least Apr 16, 2026); RayzeBio, Inc. (Director · Sep 14, 2023 – Sep 14, 2023 · Past); Ventyx Biosciences Inc (Director · Oct 20, 2021 – Jun 9, 2022 · Past)
Director · Jun 19, 2019 – Jun 24, 2019 · Past
Andrew Cheng
Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Aug 10, 2026); TCGX Acquisition Corp. (Director · Since at least Aug 4, 2026); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Arbutus Biopharma Corporation (Director · Aug 17, 2019 – Jun 3, 2021 · Past)
President and CEO, Director · Since at least Jun 19, 2019
Seth L. Harrison
Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Oct 20, 2015 · Past); Eledon Pharmaceuticals, Inc. (Director · Sep 16, 2014 – Jun 15, 2016 · Past); HeartWare International Inc (Director · Jun 28, 2007 – Aug 23, 2016 · Past)
Director · Since at least Jun 19, 2019
G Walmsley Graham
Other companies: Olema Pharmaceuticals, Inc. (Director · Since at least Jun 1, 2020); LifeSci Acquisition II Corp (Director · Nov 20, 2020 – Nov 20, 2020 · Past); ALX Oncology Holdings Inc. (Director · Jul 16, 2020 – Jun 11, 2021 · Past)
Director · Since at least Jun 19, 2019
Kevin Bitterman
Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Editas Medicine, Inc. (Director · Feb 2, 2016 – Jun 15, 2017 · Past)
Director · Jun 19, 2019 – Jun 1, 2021 · Past
William Richard White
Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021)
Chief Financial Officer · Since at least Jun 19, 2019
Yuan Xu
Other companies: Xilio Therapeutics, Inc. (Board Member · Since at least Jan 4, 2022); Fate Therapeutics, Inc. (Board Member · Since at least Aug 3, 2021)
Director · Since at least Apr 22, 2021
All 16 people
PersonSeat
Catriona YaleChief Development Officer · Since at least Jun 19, 2019
Chou JudyDirector · Since at least Jul 12, 2021
Jonathan YoungChief Operating Officer · Since at least Jun 19, 2019
Patrick LamySee Remarks · Since at least Jan 10, 2023
Scott A GangloffChief Technology Officer · Since at least Apr 29, 2024
Timothy RolphChief Scientific Officer · Since at least Jun 19, 2019

Open People

Log in to ask 6ix AI your own questions about Akero Therapeutics Inc.